Sign in
Not yet taking people in United StatesPhase 2

THiamine for Recovery In Vulnerable Early-life Infections

Key facts

Who runs it
Milton S. Hershey Medical Center
Where
Boston and Hershey, United StatesSee the 2 sites
Trial code
Status
Not yet recruiting
Phase
Phase 2
People taking part
240 people, planned
Starts
1 Dec 2026
Expected to end
30 Nov 2031
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • thiamine hydrochloride 100 mg
  • Placebo
Record updated
9 October 2026

Who can take part

Age
Up to 12 months
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • ≤12 months old
  • Clinical concern for bacteremia or meningitis (fever or hypothermia and lethargy; fever or hypothermia and poor feeding; fever or hypothermia and seizure, bulging fontanelle or nuchal rigidity)
  • Legal guardian has provided informed consent
  • No known neurologic or developmental comorbidity (e.g. trisomy 21, congenital structural brain abnormality)
  • Weight ≥ 2kg

Who cannot take part

  • Prior episode of bacteremia or meningitis
  • Already receiving thiamine as standard-of-care
  • Known neurologic or developmental comorbidity including genetic disorders
  • Weight < 2 kg

Where in United States

  • Boston Children's HospitalBoston, United StatesContact: Sarah U. Morton, MD, PhDNot yet recruiting
  • Penn State Health Milton S. Hershey Medical CenterHershey, United StatesContact: Brennen Harding, MSNot yet recruiting

About the trial

What the trial wants to find out

To determine if the addition of thiamine to standard-of-care treatment will improve neurodevelopmental outcomes for infants with meningitis or bacteremia

The 2 groups in the trial

  • ThiamineTreatment being tested

    Participant will receive IV thiamine in addition to standard of care treatment

    Treatment: thiamine hydrochloride 100 mg

  • PlaceboPlacebo, for comparison

    Participant will receive placebo (IV saline solution) in addition to standard-of-care treatment.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 October 2026